BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 25788544)

  • 1. Has CXCL13 an added value in diagnosis of neurosyphilis?
    Mothapo KM; Verbeek MM; van der Velden LB; Ang CW; Koopmans PP; van der Ven A; Stelma F
    J Clin Microbiol; 2015 May; 53(5):1693-6. PubMed ID: 25788544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of CXCL13 in diagnosing asymptomatic neurosyphilis in HIV-infected patients.
    Hu R; Lu C; Lu S; Hu Y; Ma H; Lai W; Zhu G; Feng P; Lu R; Li Y
    Int J STD AIDS; 2016 Feb; 27(2):141-6. PubMed ID: 25769888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis.
    Marra CM; Tantalo LC; Sahi SK; Maxwell CL; Lukehart SA
    Sex Transm Dis; 2010 May; 37(5):283-7. PubMed ID: 20393380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients.
    Wang C; Wu K; Yu Q; Zhang S; Gao Z; Liu Y; Ni L; Cheng Y; Guan Z; Shi M; Lu H; Lou Y; Zhou P
    Sci Rep; 2016 Sep; 6():33569. PubMed ID: 27650493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic role of CXCL13 and CSF serology in patients with neurosyphilis.
    Li D; Huang X; Shi M; Luo L; Tao C
    Sex Transm Infect; 2021 Nov; 97(7):485-489. PubMed ID: 33436504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid CXCL13 concentration for diagnosis of neurosyphilis: a systematic review and meta-analysis.
    Du FZ; Zhang X; Zheng XL; Zhang RL; Wang QQ
    BMJ Open; 2024 May; 14(5):e078527. PubMed ID: 38821573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurosyphilis in HIV-infected patients.
    Bordón J; Martínez-Vázquez C; Alvarez M; Miralles C; Ocampo A; de la Fuente-Aguado J; Sopeña-Perez Arguelles B
    Eur J Clin Microbiol Infect Dis; 1995 Oct; 14(10):864-9. PubMed ID: 8605899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage migration inhibitory factor as a novel cerebrospinal fluid marker for neurosyphilis among HIV-negative patients.
    Lin LR; Lin DH; Tong ML; Liu LL; Fan JY; Zhu XZ; Gao K; Chen MJ; Zheng WH; Zhang HL; Li SL; Lin HL; Lin ZF; Niu JJ; Yang TC
    Clin Chim Acta; 2016 Dec; 463():103-108. PubMed ID: 27751728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syphilis and neurosyphilis: HIV-coinfection and value of diagnostic parameters in cerebrospinal fluid.
    Merins V; Hahn K
    Eur J Med Res; 2015 Oct; 20():81. PubMed ID: 26445822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid CXCL13 concentration for diagnosis and monitoring of neurosyphilis in people with HIV.
    Carvalho RS; Rangel IC; Soane MM; Bacarov NBS; Herbst V; Ferry FRA
    AIDS; 2024 Apr; 38(5):657-668. PubMed ID: 38079581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid human immunodeficiency virus viral load in patients with neurosyphilis.
    de Almeida SM; Bhatt A; Riggs PK; Durelle J; Lazzaretto D; Marquie-Beck J; McCutchan A; Letendre S; Ellis R
    J Neurovirol; 2010 Feb; 16(1):6-12. PubMed ID: 20132081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant Humoral Immune Responses in Neurosyphilis: CXCL13/CXCR5 Play a Pivotal Role for B-Cell Recruitment to the Cerebrospinal Fluid.
    Yu Q; Cheng Y; Wang Y; Wang C; Lu H; Guan Z; Huang J; Gong W; Shi M; Ni L; Wu J; Peng R; Zhou P
    J Infect Dis; 2017 Sep; 216(5):534-544. PubMed ID: 28931218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV and syphilis: when to perform a lumbar puncture.
    Libois A; De Wit S; Poll B; Garcia F; Florence E; Del Rio A; Sanchez P; Negredo E; Vandenbruaene M; Gatell JM; Clumeck N
    Sex Transm Dis; 2007 Mar; 34(3):141-4. PubMed ID: 16865051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis.
    Dersch R; Hottenrott T; Senel M; Lehmensiek V; Tumani H; Rauer S; Stich O
    Fluids Barriers CNS; 2015 May; 12():12. PubMed ID: 25975424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the cerebrospinal fluid (CSF) toluidine red unheated serum test and the CSF rapid plasma reagin test with the CSF venereal disease research laboratory test for diagnosis of neurosyphilis among HIV-negative syphilis patients in China.
    Zhu L; Gu X; Peng RR; Wang C; Gao Z; Zhou P; Gao Y; Shi M; Guan Z; Seña AC
    J Clin Microbiol; 2014 Mar; 52(3):736-40. PubMed ID: 24335955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syphilis and neurosyphilis in human immunodeficiency virus-infected patients: a retrospective study at a teaching hospital in Taiwan.
    Wang YJ; Chi CY; Chou CH; Ho CM; Lin PC; Liao CH; Ho MW; Wang JH
    J Microbiol Immunol Infect; 2012 Oct; 45(5):337-42. PubMed ID: 22698630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL13 and TH1/Th2 cytokines in the serum and cerebrospinal fluid of neurosyphilis patients.
    Yan Y; Wang J; Qu B; Zhang Y; Wei Y; Liu H; Wu C
    Medicine (Baltimore); 2017 Nov; 96(47):e8850. PubMed ID: 29381995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine Ligand 13 (CXCL13) in Neuroborreliosis and Neurosyphilis as Selected Spirochetal Neurological Diseases: A Review of Its Diagnostic Significance.
    Gudowska-Sawczuk M; Mroczko B
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential for CXCL13 in CSF as a differential diagnostic tool in central nervous system infection.
    Masouris I; Klein M; Ködel U
    Expert Rev Anti Infect Ther; 2020 Sep; 18(9):875-885. PubMed ID: 32479125
    [No Abstract]   [Full Text] [Related]  

  • 20. CXCL13 chemokine as a promising biomarker to diagnose neurosyphilis in HIV-negative patients.
    Zeng YL; Lin YQ; Zhang NN; Zou CN; Zhang HL; Peng F; Liu ZJ; Zheng WH; Yan JH; Liu LL
    Springerplus; 2016; 5(1):743. PubMed ID: 27376011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.